Hybrid coronary revascularization vs. PCI in high-risk multivessel coronary artery disease: a two-center, two-year utcome comparison
Despite longer hospitalization and higher costs, HCR was associated with superior long-term symptom relief and lower MACCE compared with PCI in high-risk MV-CAD. These findings support HCR as a viable strategy in carefully selected patients and warrant validation in prospective multicenter studies.
Authors
- Lingzhi Qiu
- Ting Luo (ORCID: https://orcid.org/0000-0002-8648-2578)
- Dongwon Yi (ORCID: https://orcid.org/0000-0003-3574-036X)
- Dan Song
- Xufa Chen
- Zhengdong Hua (ORCID: https://orcid.org/0009-0007-1732-1184)
- Xiaodie Xu
- Hua Yan (ORCID: https://orcid.org/0000-0002-7651-840X)
- Bingyin Wang
- Zhijian Yang (ORCID: https://orcid.org/0000-0003-4175-2631)
Institutions
- Wuhan University (CN)
- Wuhan Asia Heart Hospital (CN)
- Wuhan General Hospital of Guangzhou (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3389/fcvm.2025.1661189
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00